Tetra Bio-Pharma (OTC: TBPMF) Receives Second Compliant Rating on Inspection from Health Canada
Tetra Bio-Pharma Inc. receives a Notice of Compliant rated inspection to distribute pharmaceuticals Key milestone in the development path to commercialization of Reduvo OTTAWA, ON/ April 1, 2021 / Tetra Bio-Pharma Inc. (“Tetra” or the “Company”)(TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), […]
